Comparison between Lixiana vs Xarelto
| Parameter | Lixiana | Xarelto |
|---|---|---|
| Class | DOAC Xa inhibitor | DOAC Xa inhibitor |
| Mechanism | Factor Xa inhibition | Factor Xa inhibition |
| Onset | Rapid | Rapid |
| Monitoring | None | None |
| Dosing | OD | OD |
| Half-life | ~10-14h | ~5-13h |
| Reversal Agent | PCC | PCC |
| Bleeding Risk | Moderate | Moderate |
| Indications | AF/VTE | AF/VTE |
| Renal Use | Caution | Caution |
| Pregnancy Use | Avoid | Avoid |
| Drug Interactions | Moderate | Moderate |
| Adherence Sensitivity | High | High |
| Best Use Case | Alternative DOAC | Established DOAC |
| Cost | High | High |
| Monitoring Burden | Low | Low |
| Clinical Flexibility | Moderate | Moderate |
| Real-world Convenience | High | High |
| Overall Verdict | Alternative | Established |
| Food Interactions | None | None |